ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3,1,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
4,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
5,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
6,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
7,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
8,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
8,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
8,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
9,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
10,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
10,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
11,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
11,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,3,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
12,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
13,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
13,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
14,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
14,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
15,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
16,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
17,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
18,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
19,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
19,3,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
20,1,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
20,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
20,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
20,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
21,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
21,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
21,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
21,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
22,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
22,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
22,3,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
23,1,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
24,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
25,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
26,1,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
26,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
26,3,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
26,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
27,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
27,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
27,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
27,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
27,5,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
27,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
27,7,Gastrointestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
27,8,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
27,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
27,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
28,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
29,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
30,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
31,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
31,2,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
31,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
31,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
31,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
32,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
33,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
33,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
33,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
33,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,5,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
34,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
34,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
35,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
36,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
37,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
38,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
38,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
39,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
39,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
39,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
40,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
40,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
41,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
42,1,Locked-in syndrome,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
42,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
42,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
43,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
43,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
44,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
44,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
44,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
44,4,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
45,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
45,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
46,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
46,2,Simple partial seizures,Partial simple seizures NEC,Seizures (incl subtypes),Nerv,N
47,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
47,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
48,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
48,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
49,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
49,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
49,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
49,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
49,5,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
50,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
50,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
51,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
51,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
51,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
52,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
53,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
54,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
55,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
55,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
56,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
56,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
57,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,Y
58,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
59,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
59,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
59,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
59,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
60,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
60,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
60,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
60,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
61,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
61,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
61,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
62,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
63,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
64,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
65,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
66,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
67,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
68,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
69,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
70,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
71,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
71,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
72,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
72,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
72,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
73,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
74,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
74,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
75,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
76,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
77,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
77,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
78,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
78,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
78,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
78,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
79,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
79,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
79,3,Blood alkaline phosphatase abnormal,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
79,4,Blood bilirubin abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
79,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
79,6,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
79,7,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
79,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
79,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
79,10,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
79,11,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
79,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
79,13,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
79,14,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
79,15,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
79,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
79,17,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
79,18,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
79,19,Transaminases abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
79,20,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
80,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
81,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
81,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
82,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
83,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
83,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
83,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
84,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
84,2,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
84,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
84,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
85,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
86,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
86,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
86,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
87,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
87,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
88,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
88,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
89,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
90,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
91,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
92,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
92,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
92,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
93,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
94,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
94,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
95,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
96,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
96,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
96,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
96,4,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
96,5,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
96,6,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
97,1,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
97,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
97,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
98,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
98,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
99,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
99,2,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
99,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
100,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
100,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
101,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
102,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
103,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
104,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
104,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
105,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
105,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
106,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
106,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
107,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
108,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
108,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
109,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
109,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
109,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
109,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
110,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
111,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
111,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
111,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
111,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
111,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
111,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
112,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
112,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
112,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
113,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
114,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
114,2,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
115,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
115,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
115,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
116,1,Aspartate aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
116,2,Headache,Headaches NEC,Headaches,Nerv,N
116,3,Hepatic ischaemia,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
116,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
116,5,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
116,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
117,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
117,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
118,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
119,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
120,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
120,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
120,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
120,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
121,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
121,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
121,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
122,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
123,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
123,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
123,3,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
123,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
123,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
123,6,Locked-in syndrome,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
123,7,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
123,8,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
123,9,Osmotic demyelination syndrome,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
123,10,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
123,11,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
123,12,Quadriplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
123,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
124,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
124,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
124,3,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
124,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
124,5,Osmotic demyelination syndrome,Demyelinating disorders NEC,Demyelinating disorders,Nerv,Y
125,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
126,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
126,2,Disability,Disability issues,Lifestyle issues,SocCi,N
126,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
126,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
126,5,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
126,6,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
126,7,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
127,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
128,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
128,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
129,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
130,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
131,1,Ewing's sarcoma recurrent,Bone sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
132,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
132,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
132,3,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
132,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
132,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
133,1,Blood pressure diastolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
133,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
133,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
133,4,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
133,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
133,6,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
134,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
135,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
135,2,Depressive symptom,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
136,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
137,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
137,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
137,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
137,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
138,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
139,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
140,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
141,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
142,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
143,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
143,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
143,3,Glioblastoma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
143,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
143,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
143,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
143,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
144,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
144,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
144,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
144,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
144,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
144,6,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
144,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
144,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
145,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
145,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
145,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
145,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
145,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
145,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
145,7,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
145,8,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
145,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
145,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
146,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
146,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
146,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
146,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
146,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
146,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
147,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
147,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
147,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
147,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
147,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
147,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
148,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
148,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
148,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
148,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
148,5,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
148,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
148,7,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
148,8,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
148,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
148,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
148,11,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
148,12,Otitis media,Ear infections,Infections - pathogen unspecified,Infec,N
148,13,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
148,14,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
148,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
149,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
149,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
149,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
149,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
149,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
149,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
149,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
149,8,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
149,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
149,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
150,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
150,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
150,3,Headache,Headaches NEC,Headaches,Nerv,N
150,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
150,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
150,6,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
150,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
150,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
151,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
151,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
151,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
151,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
151,5,Headache,Headaches NEC,Headaches,Nerv,N
151,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
151,7,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
151,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
151,9,Otitis media,Ear infections,Infections - pathogen unspecified,Infec,N
152,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
152,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
152,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
152,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
152,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
152,6,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
152,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
152,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
153,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
153,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
153,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
153,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
153,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
153,6,Primitive neuroectodermal tumour,Nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
153,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
153,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
154,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
154,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
154,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
154,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
154,5,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
154,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
154,7,Headache,Headaches NEC,Headaches,Nerv,N
154,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
154,9,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
154,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
154,11,Otitis media,Ear infections,Infections - pathogen unspecified,Infec,N
154,12,Primitive neuroectodermal tumour,Nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
155,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
155,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
155,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
155,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
155,5,Headache,Headaches NEC,Headaches,Nerv,N
155,6,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
155,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
155,8,Primitive neuroectodermal tumour,Nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
155,9,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
155,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
155,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
156,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
156,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
156,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
156,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
156,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
156,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
156,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
156,8,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
156,9,Primitive neuroectodermal tumour,Nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
156,10,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
156,11,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
156,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
157,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
157,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
157,3,Astrocytoma malignant,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
157,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
157,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
157,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
157,7,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
157,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
157,9,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
157,10,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
157,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
157,12,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
157,13,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
157,14,Otitis media,Ear infections,Infections - pathogen unspecified,Infec,N
157,15,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
157,16,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
157,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
158,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
158,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
158,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
158,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
158,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
158,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
158,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
158,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
158,9,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
158,10,Spindle cell sarcoma,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,Y
158,11,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
158,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
159,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
159,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
159,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
159,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
159,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
159,6,Primitive neuroectodermal tumour,Nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
159,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
159,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
160,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
161,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
161,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
161,3,T-cell lymphoma,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
161,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
162,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
163,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
163,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
163,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
164,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,Y
164,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
165,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
166,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
166,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
166,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
167,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
168,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
169,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
170,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
171,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
171,2,Pancreatic neoplasm,Gastrointestinal neoplasms malignancy unspecified NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
172,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
173,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
173,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
173,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
173,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
174,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
174,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
174,3,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
174,4,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
174,5,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
174,6,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
174,7,Lymphocyte morphology abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
174,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
174,9,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
174,10,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
174,11,Urticaria papular,Urticarias,Angioedema and urticaria,Skin,N
175,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
175,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
176,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
176,2,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
176,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
176,4,Headache,Headaches NEC,Headaches,Nerv,N
176,5,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
176,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
176,7,Pseudomonal sepsis,Pseudomonal infections,Bacterial infectious disorders,Infec,Y
176,8,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
176,9,Tumour necrosis,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
176,10,Vasogenic cerebral oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
176,11,White matter lesion,Structural brain disorders NEC,Structural brain disorders,Nerv,N
177,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
178,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
178,2,Desmoplastic small round cell tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
178,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
178,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
178,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
178,6,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
178,7,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
178,8,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
178,9,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
178,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
178,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
178,12,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
179,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
180,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
180,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
180,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
180,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
181,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
181,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
181,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
181,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
181,5,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
181,6,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
181,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
182,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
182,2,Desmoplastic small round cell tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
182,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
182,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
182,5,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
182,6,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
182,7,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
182,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
183,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
183,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
183,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
184,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
184,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
184,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
185,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
186,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
187,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
187,2,Rhabdoid tumour,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
188,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
188,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
188,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
188,4,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
189,1,5-hydroxyindolacetic acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
189,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
189,3,Blood gastrin increased,"Gastrointestinal, pancreatic and APUD hormone analyses",Endocrine investigations (incl sex hormones),Inv,N
189,4,Bone loss,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
189,5,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
189,6,Borderline ovarian tumour,Female reproductive neoplasms unspecified malignancy,Reproductive neoplasms female malignant and unspecified,Neopl,N
189,7,Bronchial carcinoma,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
189,8,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
189,9,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
189,10,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
189,11,Hyperplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
189,12,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
189,13,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
189,14,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
189,15,Metastases to spine,Metastases to specified sites,Metastases,Neopl,N
189,16,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
189,17,Neuroendocrine tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
189,18,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
189,19,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
189,20,Pelvic mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
189,21,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
189,22,Pulmonary hilum mass,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
189,23,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
189,24,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
189,25,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
189,26,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
190,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
191,1,Glioblastoma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
191,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
192,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
193,1,Choluria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
193,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
193,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
193,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
193,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
193,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
194,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
195,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
196,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
197,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
197,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
198,1,Osteosarcoma metastatic,Bone sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,Y
199,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
199,2,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
200,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
201,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
202,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
202,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
203,1,Astrocytoma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
203,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
204,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
204,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
204,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
205,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
205,2,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
206,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
206,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
207,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
207,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
208,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
208,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
209,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
209,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
210,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
210,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
211,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
211,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
211,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
211,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
212,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
212,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
212,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
212,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
213,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
213,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
213,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
213,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
214,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
214,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
215,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
215,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
216,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
216,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
217,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
218,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
218,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
218,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
218,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
218,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
218,6,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
218,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
218,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
219,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
220,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
220,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
221,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
222,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
222,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
223,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
223,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
224,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
224,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
225,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
226,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
226,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
226,3,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
226,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
227,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
227,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
228,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
229,1,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
229,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
230,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
231,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
231,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
231,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
231,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
231,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
231,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
232,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
232,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
232,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
233,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
233,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
233,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
234,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
234,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
234,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
235,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
235,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
235,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
236,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
236,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
237,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
238,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
239,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
239,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
239,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
239,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
239,5,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
240,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
240,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
240,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
240,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
240,5,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
241,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
241,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
241,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
242,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
242,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
243,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
244,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
245,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
246,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
247,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
247,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
247,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
248,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
248,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
249,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
249,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
249,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
249,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
250,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
250,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
250,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
251,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
251,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
252,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
252,2,Headache,Headaches NEC,Headaches,Nerv,N
252,3,Hepatic pain,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
252,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
252,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
252,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
252,7,Pancreatic neuroendocrine tumour,Islet cell neoplasms and APUDoma NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
252,8,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
252,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
253,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
254,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
254,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
255,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
256,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
256,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
257,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
257,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
257,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
257,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
257,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
258,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
258,2,Cerebral mass effect,Structural brain disorders NEC,Structural brain disorders,Nerv,N
258,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
258,4,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
258,5,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
258,6,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
259,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
259,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
260,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
260,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
